Oncology ⋆ Page 27 of 47 ⋆ eMEDICAL BOOKS

Behavioural Oncology: Psychological, Communicative, and Social Dimensions 2014th Edition

October 27, 2017

[amazon template=image&asin=1461496047]

Medical, educational, and public health efforts have reduced the spread of many major diseases, yet cancer perseveres, in spite of continuing research and improvements in practice. Especially promising among therapeutic strategies are ones that recognise patients as individuals with thoughts, feelings–and speech.

Rooted in deep understanding of the mutual relationship between behavior and cancer, Behavioural Oncology combines extensive clinical wisdom and empirical data to illuminate the psychological, social, and existential aspects of cancer, and to offer a framework for empathic, patient-centered care. Chapters delve into the psychobiology of long-term illness, examining stress, pain, fatigue, sensory and sleep disturbances, and other quality of life issues as well as considerations of age, gender, culture, and comorbidity. The book’s emphasis on linguistic and communicative aspects of cancer–and practical skills from respecting patient narratives to delivering bad news–adds necessary depth to concepts of the therapeutic relationship. In this way, the authors warn about overmedicalizing cases to the point of losing patient identity. Major areas of the coverage include:

Biology and behavior in cancer prevention and suppression.
The psychology of cancer patients: emotions, cognition, and personality
Social dimensions, including stigma, coping, and social support
Language, communication, and cross-cultural issues
Existential, spiritual, and end-of-life concerns
Doctor-patient relationships
The psychological benefits of complementary therapies

Bringing new scope and substance to familiar mind/body constructs, Behavioural Oncology is a definitive reference for a spectrum of healthcare professionals, among them health and clinical psychologists, oncologists and family physicians, oncology nurses, and clinical social workers. Its discussion questions and summaries make it a suitable text for undergraduate and graduate courses in related topics.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/Fqa4SCD

Oncology

Lung Cancer and Personalized Medicine: Current Knowledge and Therapies (Advances in Experimental Medicine and Biology) 1st ed

October 24, 2017

[amazon template=image&asin=3319242210]

“The aim of this book is to discuss current knowledge about lung cancer with a specific focus on non-small-cell lung cancer (NSCLC). … The intended audience is established researchers, clinicians, healthcare professionals, and students in the medical and scientific community. … The authors have successfully compiled a well-written, comprehensive, and robust book about NSCLC … .” (Karen L. Reckamp, Doody’s Book Reviews, August, 2016)

From the Back Cover

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer―statistics and epidemiology of lung cancer―along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer―immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FjnHdEa

D-type Cyclins and Cancer (Current Cancer Research) 1st ed. 2018 Edition

October 24, 2017

[amazon template=image&asin=3319644491]

This volume provides an integrated account of our current understanding of the functions of D-type cyclins during development and tumorigenesis, with special emphasis on the kinase-independent functions of these proteins. The volume will provide a thorough review of the latest discoveries on the new functions and interacting partners of mammalian cyclin Ds crucial to explain their oncogenic and differentiation properties in different cellular contexts. The volume begins with a historical perspective of how D-type cyclins were first discovered and eventually cloned from cancer tissues, followed by an account on the canonical functions of cyclin Ds during the G1-S transition of the cell cycle. Several chapters will be devoted to review the functions of D-type cyclins as transcriptional regulators and the mechanisms through which these novel functions could impact the tumorigenic process. Also discussed is emerging evidence that points to a role of D-type cyclins, particularly cyclin D1, as a cytoplasmic regulator of various cellular functions. This property, in human cells at least, is traceable to certain splice isoforms with novel oncogenic implications. Finally, a chapter is devoted to recent efforts to revise the canonical view of the “retinoblastoma pathway” to incorporate new evidence that suggests that cyclin D1’s role in G1 is to singly-phosphorylate the retinoblastoma protein (pRb) for discrimination of target protein interactions. This work represents a significant departure from the view of cyclin D1 as a negative regulator of pRb and may have critical implications for understanding the function of antineoplastic agents that target the cyclin D1-associated kinases.

About the Author

Philip W. Hinds is Professor and Chair of the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine. He is also the Deputy Director of Tufts Medical Cancer Center. Dr. Hinds is an expert in cell cycle control and its dysregulation in cancer cells. He participates in several journal editorial boards including the Journal of Biological Chemistry, the Chinese Journal of Cancer, and Cancer Research to name a few.

Nelson E. Brown is currently Associate Professor at the University of Talca School of Medicine in Chile. He is also Director of the Center for Medical Research at the University of Talca. His current work focuses on the role of cyclin D1-associated kinase activity in senescence and tumorigenesis

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FjoaTG7

Oncology

Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease 1st ed. 2017 Edition

October 24, 2017

[amazon template=image&asin=3319430947]

Co-edited and written by an interdisciplinary team of experts in oncology and cardiology, this book is a clinically useful resource on these overlapping topics:

• Cardiac complications in patients receiving cancer therapy

• The treatment of cancer in patients with cardiovascular disease

• The treatment of cardiovascular disease in patients with cancer

When relevant to medical practice, epidemiology and basic science are also included in the discussion and each chapter is written by an oncologist and a cardiologist. Additionally, the chapters follow a similar format to make the book truly interdisciplinary, user-friendly, and clinically applicable to specialists and non-specialists who care for patients with both cancer and cardiovascular disease.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FqCxdtr

Handbook of Long Term Care of The Childhood Cancer Survivor (Specialty Topics in Pediatric Neuropsychology) 1st ed

October 20, 2017

[amazon template=image&asin=1489975837]

This authoritative reference examines in depth the myriad challenges facing pediatric cancer survivors and proposes a robust framework for structured follow-up of these patients through adulthood. Approaches to long-term follow-up include both established models of care and targeted models of lifelong surveillance of late effects by bodily systems and neurological outcomes. Sections devoted to quality of life and re-entry after treatment focus on key concerns such as health risk behaviors, school and career issues, psychological challenges, and care disparities. And a robust resources section adds extra usefulness to the expert coverage.

Among the Handbook’s topics:

• Developmental considerations in the transition from child and adolescent to adult survivorship.
• Long-term follow-up roadmaps by disease and treatment.
• Neuropsychological effects of pediatric brain tumors and associated treatment.
• Building resiliency in childhood cancer survivors: a clinician’s perspective.
• School issues and educational strategies for survivors of childhood cancer.
• Educating and preparing the childhood cancer survivor for long-term care: a curriculum model for cancer centers.

A work of rare scope, scholarship, and clinical acumen, the Handbook of Long-Term Care of the Childhood Cancer Survivor is a rewarding, practice-building resource essential to a wide range of healing professionals, including primary care physicians, pediatricians, oncologists, nurses, psychologists, neuropsychologists, child psychologists, and licensed therapists.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FjA54vh

Cancer Stem Cells: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2018 Edition

October 20, 2017

[amazon template=image&asin=1493974009]

This detailed volume gathers a comprehensive collection of methods, protocols, and procedures used for the identification, characterization, and selection of cancer stem cells. These include surface marker expression, side population, spheres formation, ALDH activity, and numerous others. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and expert tips and troubleshooting advice to avoid potential pitfalls.

Comprehensive and practical, Cancer Stem Cells: Methods and Protocols provides researchers with the techniques they will need in order to pursue vital research into this complex field of study.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FjFXcC6

Oncology

Immunohistochemistry in Tumor Diagnostics 1st ed. 2018 Edition

October 20, 2017

[amazon template=image&asin=3319535765]

This book offers a comprehensive yet concise overview of immunoprofile of tumors and antibodies used in contemporary surgical pathology, and provides diagnostic algorithms for approaching tumor diagnostics.

Immunohistochemistry has become the most important ancillary technique in diagnostic pathology in the last 20 years, and unlike most books on tumor diagnostics, this volume discusses in details immunohistochemical biomarkers, diagnostic approaches and their pitfalls, as well as the immunoprofile of common tumors throughout all systems of human body. With numerous color figures and detailed flowcharts, it appeals to all pathologists be they young residents in training who want a brief introduction to this technique, or specialists in need of a reliable and comprehensive reference resource in tumors diagnostics.

About the Author

Dr. Muin S.A. Tuffaha obtained a degree in general medicine with honors (MD) from the Medical Institute Kiev, UDSSR in 1986 before passing the German Board in Pathology. He continued as specialist in pathology at the Technical University of Dresden`s Institute of Pathology. Dr. Tuffaha was the deputy head of the Department of Head and Neck Pathology at the University of Hamburg. Since 2010, Dr. Tuffaha has been head at the Institute of Pathology, Carl-Thiem-Hospital a teaching hospital of the Medical Faculty Charité, Berlin, Germany. He received an honorary Professor from the Kiev Medical University of UAFM.

Professor Hans Guski is Professor of Pathology and the former Deputy Director of the Institute of Pathology of the Humboldt University of, where he worked for more than 40 years. During this time, he mentored about 70 doctoral candidates and published over 500 scientific articles and presented papers. He is co-author of several textbooks and monographs, including a monograph on immunohistochemical studies in tumors published in Russian by Dr. Tuffaha (Kiev 2013). Professor Guski has been an ordinary member of the Russian Academy of Natural Sciences since 1992 and is an honorary member of several international medical societies. He received an honorary doctorate from the State University of Saransk, Russia, in 1996, and has been a Guest Professor of the University of Havana, Cuba, since 2004.Professor Glen Kristiansen has been a professor of pathology and chair of the Institute of Pathology, University Bonn, Germany since 2011. From 2007 to 2011, he was a professor of molecular tumor pathology and head of the Immunohistochemistry Laboratory at the Institute of Surgical Pathology, University Zurich, Switzerland. He was also resident and later consultant and head of the Immunohistochemistry Laboratory at the Institute of Pathology, Charité, Berlin, Germany (1998-2007). In 2014, he broadened his skills at the Cedars-Sinai Hospital Medical Center, Los Angeles, USA. Professor Kristiansen has authored or co-authored more than 300 scientific publications and is an acclaimed speaker at international congresses.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/Fj65476

Harrison’s Hematology and Oncology, 3E (Harrison’s Specialty) 3rd Edition

October 19, 2017

[amazon template=image&asin=1259835839]

Hematology and Oncology – backed by the unmatched authority of Harrison’s

A Doody’s Core Title for 2017!

Featuring a superb compilation of chapters related to hematology and oncology derived from Harrison’s Principles of Internal Medicine, Nineteenth Edition (including content from the acclaimed Harrison’s DVD, now available here in print), this concise, full-color clinical companion delivers the latest knowledge in the field backed by the scientific rigor and authority that have defined Harrison’s. You will find 57 chapters from more than 75 renowned editors and contributors in a carry-anywhere presentation that is ideal for the classroom, clinic, ward, or exam/certification preparation.

Features:

Each chapter contains relevant information on the genetics, cell biology, pathophysiology, and treatment of specific disease entities
• Chapters on hematopoiesis, cancer cell biology, and cancer prevention reflect the rapidly growing knowledge in these areas
• Integration of pathophysiology with clinical management
• High-yield board review questions make this text ideal for keeping current or preparing for the boards
• Valuable appendix of laboratory values of clinical importance

DOWNLOAD THIS BOOK FREE HERRE

http://upsto.re/Fx4XvyY

Cancer: A Beginner’s Guide (Beginner’s Guides)

October 18, 2017

[amazon template=image&asin=1851687556]

Cancer is the second biggest killer in the world, but few of us understand how it works or how it is treated. In this illuminating introduction, Paul Scotting explains the science behind the disease and explores why some of us are more likely to develop it than others. Arguing that we’re in a new age of understanding that will revolutionize the fight againtst cancer, Scotting maps out the promising future strategies for its prevention, treatment, and cure.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FxcE7at

Oncology

Tumor Dormancy and Recurrence (Cancer Drug Discovery and Development) 1st ed. 2017 Edition

October 18, 2017

[amazon template=image&asin=3319592408]

This volume will be the first to provide a comprehensive description of tumor dormancy. It will define the clinical and biological aspects of this phenomenon, as well as the cellular and molecular mechanisms associated with tumor dormancy. Chapters will be authored by world-renewed experts who are conducting cutting-edge research in the field. A unique feature will be a conclusive paragraph detailing future development and foreseeable clinical applications at the end of each chapter. The volume will serve as a fundamental instrument for every researcher and clinician interested in the field of tumor dormancy as well as a means of disseminating stimulating concepts and prompting the development of innovative technological solutions.

About the Author

Yuzhuo Wang, PhD, is Distinguished Scientist, Department of Experimental Therapeutics, BC Cancer Agency, Cancer Research Centre, Vancouver Prostate Centre, University of British Columbia, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Francesco Crea, PhD, is Post Doctoral Fellow, Department of Experimental Therapeutics, BC Cancer Agency, Cancer Research Centre, Vancouver Prostate Centre, University of British Columbia, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FxBFw3J

Oncology

« 1 … 25 26 27 28 29 … 47 »